JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB264869

Human TACC2 knockout HeLa cell line

Be the first to review this product! Submit a review

|

(0 Publication)

TACC2 KO cell line available to order. KO validated by. Free of charge wild type control provided. Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 9.

View Alternative Names

AZU 1, Anti zuai 1, ECTACC, Transforming acidic coiled coil containing protein 2

1 Images
Sanger Sequencing - Human TACC2 knockout HeLa cell line (AB264869)
  • Sanger seq

Unknown

Sanger Sequencing - Human TACC2 knockout HeLa cell line (AB264869)

Homozygous : 1 bp insertion in exon 9.

Key facts

Cell type

HeLa

Species or organism

Human

Tissue

Cervix

Form

Liquid

form

Knockout validation

Sanger Sequencing

Mutation description

Knockout achieved by using CRISPR/Cas9, Homozygous: 1 bp insertion in exon 9

Disease

Adenocarcinoma

Product details

Recommended control: Human wild-type HeLa cell line (ab255448). Please note a wild-type cell line is not automatically included with a knockout cell line order, if required please add recommended wild-type cell line at no additional cost using the code WILDTYPE-TMTK1.

We will provide viable cells that proliferate on revival.

This product is subject to limited use licenses from The Broad Institute, ERS Genomics Limited and Sigma-Aldrich Co. LLC, and is developed with patented technology. For full details of the licenses and patents please refer to our limited use license and patent pages.

What's included?

{ "values": { "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab264869-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab264869 Human TACC2 knockout HeLa cell line", "number":"AB264869-CMP01" } ] }, "1000000Cellsvial": { "sellingSize": "1000000 Cells/vial", "publicAssetCode":"ab264869-1000000Cells_vial", "assetComponentDetails": [ { "size":"1 x 1000000 Cells/vial", "name":"ab264869 Human TACC2 knockout HeLa cell line", "number":"AB264869-CMP01", "productcode":"" } ] } } }

Properties and storage information

Gene name
TACC2
Gene editing type
Knockout
Gene editing method
CRISPR technology
Knockout validation
Sanger Sequencing
Zygosity
Homozygous
Shipped at conditions
Dry Ice
Appropriate short-term storage conditions
-196°C
Appropriate long-term storage conditions
-196°C

Handling procedures

Initial handling guidelines

Upon arrival, the vial should be stored in liquid nitrogen vapor phase and not at -80°C. Storage at -80°C may result in loss of viability.

1. Thaw the vial in 37°C water bath for approximately 1-2 minutes.
2. Transfer the cell suspension (0.8 mL) to a 15 mL/50 mL conical sterile polypropylene centrifuge tube containing 8.4 mL pre-warmed culture medium, wash vial with an additional 0.8 mL culture medium (total volume 10 mL) to collect remaining cells, and centrifuge at 201 x g (rcf) for 5 minutes at room temperature. 10 mL represents minimum recommended dilution. 20 mL represents maximum recommended dilution.
3. Resuspend the cell pellet in 5 mL pre-warmed culture medium and count using a haemocytometer or alternative cell counting method seed all remaining cells into a T25.
4. Incubate the culture at 37°C incubator with 5% CO2. Check the culture one day after revival and continue to check until 80% confluent. Media change can be given if needed.
5. Once confluent passage into an appropriate flask at a density of 2x104 cells/cm2. Seeding density is given as a guide only and should be scaled to align with individual lab schedules. Cultures should be monitored daily.

Subculture guidelines
  • All seeding densities should be based on cell counts gained by established methods.
  • A guide seeding density of 2x104 cells/cm2 is recommended.
  • Cells should be passaged when they have achieved 80-90% confluence.
Culture medium

DMEM (High Glucose) + 10% FBS

Cryopreservation medium

Cell Freezing Medium-DMSO Serum free media, contains 8.7% DMSO in MEM supplemented with methyl cellulose.

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

TACC2 also known as Transforming Acidic Coiled-Coil-Containing Protein 2 is a protein involved in cell cycle regulation. It has a molecular mass of approximately 146 kDa and is expressed in various tissues with notable expression in the brain. TACC2 interacts with microtubules stabilizing their structure which is essential for proper mitotic spindle formation during cell division. This stabilization facilitates accurate chromosome segregation a critical aspect of cellular replication.
Biological function summary

TACC2 plays a role in centrosome-related processes and is part of a multi-protein complex involved in microtubule dynamics. The protein is particularly important in neuronal cells where it contributes to maintaining proper cell architecture and neurogenesis. Studies have shown that TACC2 interacts with components involved in chromosomal stability ensuring the faithful transmission of genetic information during cell division thereby supporting cellular homeostasis.

Pathways

TACC2 is involved in cellular pathways such as the mitotic spindle assembly checkpoint and the Aurora kinase signaling pathway. It directly interacts with Aurora A a kinase that regulates mitotic entry and centrosome maturation. Aurora A works closely with TACC2 to promote the correct formation of the mitotic apparatus ensuring successful chromosomal alignment and segregation during cell division. This cooperation is essential to maintain genomic stability and prevent aneuploidy.

TACC2 relates to cancer and neurodevelopmental disorders. Abnormal expression or mutations in TACC2 are linked to certain cancer types often involving incomplete cytokinesis due to disrupted mitotic spindle function. It also interacts with proteins like Aurora A in these contexts which can contribute to oncogenic pathways. Furthermore alterations in TACC2 function are associated with neurodevelopmental disorders highlighting its critical role in neural tissue where failure to regulate microtubule dynamics can result in developmental abnormalities.

Quality control

STR analysis

CSF1PO, D13S317, D7S820, D5S818, TH01, D16S539, TPOX

Cell culture

Biosafety level

EU: 2 US: 2

Adherent/suspension

Adherent

Gender

Female

Product protocols

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com